HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 433-444 of 1,811
Other study type icon
UnknownNCT04962334

Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for ADHD. A Randomized Double-blind, Placebo-controlled Trial

Current recruitment status is unconfirmed.

In Petah Tikva
ADHDPlacebo comparisonUp to age 10
Countries
Israel
Sponsor
Rabin Medical Center
Drug study icon
CompletedNCT00150579

SPD465 for ADHD

Official study title

A Phase III, Randomized, Double-blind, Multi-center, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 18–55
Countries
Sponsor
Shire
Drug study icon
CompletedNCT00152022

SPD465 for ADHD

Official study title

A Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 18–55
Countries
Sponsor
Shire
Other study type icon
CompletedNCT01721720

Genetic, Brain Structure, and Environmental Effects on ADHD

Official study title

The Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Bethesda
ADHDObservational studyAges 3+
Countries
United States
Sponsor
National Human Genome Research Institute (NHGRI)
Drug study icon
CompletedNCT03250013

Long-term Effects of Medication for ADHD

Official study title

Long-term Effects of Medication for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents on Cognition, Everyday Function and Quality of Life

This study has finished and is no longer accepting participants.

In Gothenburg
ADHDMedication studyAges 6–17
Countries
Sweden
Sponsor
Göteborg University
Drug study icon
CompletedNCT00307684

Safety study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in ADHD

What is this study about?

Researchers compared open label PR OROS methylphenidate, double blind PR OROS methylphenidate and placebo, tracking side effects to assess long-term safety and tolerability in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Paris
ADHDMedication studyAges 18–65
Countries
France, Switzerland, Germany, + 4 others
Sponsor
Janssen-Cilag International NV

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.